Call
for separate regulations for medical devices and OTC drugs
4th International
Conference on Pharma& Medical Devices concludes
·
Thrust
on data revolution in the pharmaceutical and medical device sector through AI
·
Mega
event concludes with 500+ Indian and International trade visitors,
CEOs’ participation and 250+ academicians and students
The 4th International Conference on Pharmaceuticals and
Medical Devices which concluded
witnessed the participation of drug
regulators from over 30 countries including Russia, Kenya, the UK, Malaysia,
Indonesia, Saudi Arabia and Uzbekistan, along
with participation of Indian drug regulators from 15 states.
The
conference was organised by the Department of Pharmaceuticals, Ministry
of Chemicals & Fertilizers and Government of India jointly with
the Federation of Indian Chambers of Commerce & Industry (FICCI).
Some of
the issues discussed at the CEOs roundtable included development of separate
medical device and over-the-counter (OTC) drug regulations act, early decision
on implementation of trade margin rationalization, addressing the issue of
Active Pharmaceutical Ingredients (APIs) price escalation imported from
China, incentivisation for innovation
in the pharmaceutical and medical device sector, greater transparency in the
functioning of National Pharmaceutical Pricing Authority (NPPA) and last but
not the least, amendments by the Ministry of Consumer Affairs for allowing
companies to utilise the mandatory CSR spending towards medicine donations into
Jan Aushadhi or Ayushman Bharat scheme.
Knowledge sessions were focused
towards promoting innovative ecosystem in India for pharmaceutical industry,
interaction with State Drug Controllers and CDSCO for facilitating ease of
doing business, initiatives for import registration procedure to enable faster
access to global market for the industry, WHO activities and plans related to
the regulation of health technologies and enabling the industry to gear up for
Ayushman Bharat, the most aspirational health scheme rolled out by the
government.
In his concluding remarks, Mr.
NavdeepRinwa, Joint Secretary, Department of Pharmaceutical, Government of India, mentioned how the
government was prioritising the pharma and medical device sector in AI
applications by bringing in task forces and other policies in place.
No comments:
Post a Comment